Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
55
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Liddy Anne M. | General Counsel | 15 | $0 | $0 | 2026-04-07 |
| Horvath Mark W. | President, Breast & Skeletal | 14 | $0 | $0 | 2026-04-07 |
| De Walt Diana | SVP, Human Resources | 3 | $0 | $0 | 2026-04-07 |
| Schnittker Brandon | President, GYN Surgical | 21 | $0 | $39.6K | 2026-04-07 |
| Mohtashami Nanaz | Director | 11 | $0 | $0 | 2026-04-07 |
| Schneiders Jennifer M | President, Diag. Solutions | 21 | $0 | $0 | 2026-04-07 |
| Mitchell Essex D | Div. President, GYN Surgical | 40 | $0 | $2.64M | 2026-04-07 |
| Verstreken Jan | Group President, International | 51 | $0 | $512.2K | 2026-04-07 |
| McMillan Wayde D. | Director | 5 | $0 | $0 | 2026-04-07 |
| COHN BENJAMIN JORDAN | Principal Accounting Officer | 98 | $0 | $6.12M | 2026-04-07 |
| Stamoulis Christiana | Director | 63 | $0 | $4.55M | 2026-04-07 |
| HANTSON LUDWIG | Director | 26 | $0 | $0 | 2026-04-07 |
| Stewart Stacey D. | Director | 14 | $0 | $0 | 2026-04-07 |
| Wendell Amy McBride | Director | 33 | $199.8K | $0 | 2026-04-07 |
| Dockendorff Charles J | Director | 35 | $504.4K | $1.26M | 2026-04-07 |
| Oberton Karleen Marie | Corp. VP and Controller | 199 | $0 | $12.46M | 2026-04-07 |
| Madaus Martin D | Director | 9 | $300.8K | $0 | 2026-04-07 |
| MACMILLAN STEPHEN P | President and CEO | 193 | $4.97M | $68.08M | 2026-04-07 |
| Anderson Erik S | Div. Pres., Breast & Skeletal | 17 | $0 | $0 | 2024-11-14 |
| Griffin John M. | General Counsel | 110 | $0 | $6.98M | 2024-11-14 |
| GARRETT SCOTT T | Director | 45 | $0 | $2.73M | 2024-03-14 |
| CRAWFORD SALLY | Director | 88 | $0 | $10.29M | 2024-03-08 |
| Dunne Peter Paul | SVP, Human Resources | 2 | $0 | $0 | 2023-12-13 |
| Hellmann Elisabeth A | SVP, Human Resources | 16 | $0 | $126.0K | 2023-11-14 |
| Nawana Namal | Director | 15 | $250.0K | $0 | 2023-03-09 |
| Thornal Kevin R | Group Pres, Global Diagnostics | 36 | $0 | $3.40M | 2022-11-15 |
| Daugherty Sean S. | Group President, BSH & Surg. | 14 | $0 | $415.2K | 2022-02-24 |
| Bebo Allison P | SVP, Human Resources | 30 | $0 | $1.06M | 2021-02-05 |
| Valenti Peter J. III | Division Pres., Breast Health | 85 | $0 | $3.26M | 2020-06-30 |
| West Thomas A. | Div President & GM, Diagnostic | 29 | $0 | $0 | 2018-12-01 |
| McMahon Robert W. | Chief Financial Officer | 47 | $0 | $0 | 2018-08-02 |
| Compton Eric B. | COO | 45 | $21.0K | $0 | 2017-12-01 |
| ULLIAN ELAINE | Director | 89 | $200.3K | $4.65M | 2017-11-14 |
| Levy Lawrence M | Director | 111 | $0 | $8.43M | 2017-10-11 |
| LEAMING NANCY | Director | 63 | $0 | $2.13M | 2017-03-08 |
| COUGHLIN CHRISTOPHER J | Director | 6 | $0 | $0 | 2017-03-08 |
| CHRISTODORO JONATHAN | Director | 16 | $0 | $0 | 2016-03-02 |
| MERKSAMER SAMUEL J. | Director | 16 | $0 | $0 | 2016-03-02 |
| LAVANCE DAVID R JR | Director | 46 | $0 | $7.81M | 2016-02-24 |
| WILSON WAYNE | Director | 38 | $0 | $7.00M | 2016-01-01 |
| STEIN JAY A | Chief Technical Officer | 38 | $0 | $1.09M | 2015-11-18 |
| Egstrand Claus | SVP and GM, International | 14 | $0 | $0 | 2015-11-06 |
| ICAHN CARL C | Other | 14 | $46.58M | $242.88M | 2015-08-04 |
| Casey Mark J | SVP, General Counsel | 75 | $0 | $4.01M | 2014-11-18 |
| Mills Roger D. | SVP & GM, Service & Operations | 29 | $0 | $377.2K | 2014-11-10 |
| Hastie Rohan | Group VP & GM, Diagnostics | 25 | $0 | $147.1K | 2014-08-06 |
| MUIR GLENN P | Executive VP and CFO | 66 | $0 | $20.25M | 2014-05-08 |
| LAVALLEE ROBERT H | SVP, Chief Accounting Officer | 33 | $0 | $1.64M | 2014-05-06 |
| Brady David J | SVP, Human Resources | 30 | $0 | $2.30M | 2013-11-18 |
| Harding David | SVP, International | 30 | $0 | $2.22M | 2013-11-18 |
| CUMMING JOHN W | President and CEO | 25 | $0 | $0 | 2013-11-18 |
| CASCELLA ROBERT | CEO and President | 39 | $0 | $3.40M | 2013-07-01 |
| SOLTANI PETER | SVP, Breast Health | 24 | $50.7K | $2.23M | 2013-06-28 |
| HULL CARL | SVP and GM of Diagnostics | 4 | $0 | $0 | 2013-02-01 |
| Williamson Steve S | SVP, GYN Surgical | 1 | $0 | $74.1K | 2012-03-07 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| COHN BENJAMIN JORDAN | Principal Accounting Officer | D To issuer deriv | 2026-04-07 | 2026-04-09 | 3,505 | — | $0 | 0 | SEC↗ |
| COHN BENJAMIN JORDAN | Principal Accounting Officer | D To issuer deriv | 2026-04-07 | 2026-04-09 | 3,509 | — | $0 | 0 | SEC↗ |
| COHN BENJAMIN JORDAN | Principal Accounting Officer | D To issuer deriv | 2026-04-07 | 2026-04-09 | 3,382 | — | $0 | 0 | SEC↗ |
| COHN BENJAMIN JORDAN | Principal Accounting Officer | D To issuer deriv | 2026-04-07 | 2026-04-09 | 7,132 | — | $0 | 0 | SEC↗ |
| COHN BENJAMIN JORDAN | Principal Accounting Officer | A Award deriv | 2026-04-07 | 2026-04-09 | 5,665 | — | $0 | 5,665 | SEC↗ |
| COHN BENJAMIN JORDAN | Principal Accounting Officer | D To issuer deriv | 2026-04-07 | 2026-04-09 | 10,861 | — | $0 | 0 | SEC↗ |
| COHN BENJAMIN JORDAN | Principal Accounting Officer | D To issuer deriv | 2026-04-07 | 2026-04-09 | 5,665 | — | $0 | 0 | SEC↗ |
| COHN BENJAMIN JORDAN | Principal Accounting Officer | D To issuer deriv | 2026-04-07 | 2026-04-09 | 7,505 | — | $0 | 0 | SEC↗ |
| Dockendorff Charles J | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 5,396 | — | $0 | 0 | SEC↗ |
| Dockendorff Charles J | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 6,523 | — | $0 | 0 | SEC↗ |
| Dockendorff Charles J | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 7,322 | — | $0 | 0 | SEC↗ |
| Dockendorff Charles J | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 5,055 | — | $0 | 0 | SEC↗ |
| Dockendorff Charles J | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 5,293 | — | $0 | 0 | SEC↗ |
| Dockendorff Charles J | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 4,210 | — | $0 | 0 | SEC↗ |
| Dockendorff Charles J | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 4,536 | — | $0 | 0 | SEC↗ |
| Dockendorff Charles J | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 5,535 | — | $0 | 0 | SEC↗ |
| HANTSON LUDWIG | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 6,523 | — | $0 | 0 | SEC↗ |
| HANTSON LUDWIG | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 5,535 | — | $0 | 0 | SEC↗ |
| HANTSON LUDWIG | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 4,536 | — | $0 | 0 | SEC↗ |
| HANTSON LUDWIG | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 7,322 | — | $0 | 0 | SEC↗ |
| HANTSON LUDWIG | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 2,012 | — | $0 | 0 | SEC↗ |
| HANTSON LUDWIG | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 4,210 | — | $0 | 0 | SEC↗ |
| HANTSON LUDWIG | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 5,293 | — | $0 | 0 | SEC↗ |
| HANTSON LUDWIG | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 5,055 | — | $0 | 0 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | D To issuer deriv | 2026-04-07 | 2026-04-09 | 768,639 | — | $0 | 0 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | D To issuer deriv | 2026-04-07 | 2026-04-09 | 151,071 | — | $0 | 0 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | D To issuer deriv | 2026-04-07 | 2026-04-09 | 152,529 | — | $0 | 0 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | D To issuer deriv | 2026-04-07 | 2026-04-09 | 123,801 | — | $0 | 0 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | D To issuer deriv | 2026-04-07 | 2026-04-09 | 118,877 | — | $0 | 0 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | D To issuer deriv | 2026-04-07 | 2026-04-09 | 106,300 | — | $0 | 0 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | D To issuer deriv | 2026-04-07 | 2026-04-09 | 117,829 | — | $0 | 0 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | D To issuer deriv | 2026-04-07 | 2026-04-09 | 117,801 | — | $0 | 0 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | A Award deriv | 2026-04-07 | 2026-04-09 | 190,400 | — | $0 | 190,400 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | D To issuer deriv | 2026-04-07 | 2026-04-09 | 190,400 | — | $0 | 0 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | D To issuer deriv | 2026-04-07 | 2026-04-09 | 159,339 | — | $0 | 0 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | D To issuer deriv | 2026-04-07 | 2026-04-09 | 160,565 | — | $0 | 0 | SEC↗ |
| Madaus Martin D | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 5,535 | — | $0 | 0 | SEC↗ |
| Madaus Martin D | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 1,016 | — | $0 | 0 | SEC↗ |
| McMillan Wayde D. | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 5,171 | — | $0 | 0 | SEC↗ |
| Mohtashami Nanaz | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 2,141 | — | $0 | 0 | SEC↗ |
| Mohtashami Nanaz | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 5,535 | — | $0 | 0 | SEC↗ |
| Mohtashami Nanaz | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 4,536 | — | $0 | 0 | SEC↗ |
| Stamoulis Christiana | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 5,055 | — | $0 | 0 | SEC↗ |
| Stamoulis Christiana | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 4,536 | — | $0 | 0 | SEC↗ |
| Stamoulis Christiana | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 4,210 | — | $0 | 0 | SEC↗ |
| Stamoulis Christiana | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 5,293 | — | $0 | 0 | SEC↗ |
| Stamoulis Christiana | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 5,535 | — | $0 | 0 | SEC↗ |
| Stamoulis Christiana | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 7,322 | — | $0 | 0 | SEC↗ |
| Stamoulis Christiana | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 6,523 | — | $0 | 0 | SEC↗ |
| Stamoulis Christiana | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 7,551 | — | $0 | 0 | SEC↗ |
| Stamoulis Christiana | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 6,816 | — | $0 | 0 | SEC↗ |
| Stewart Stacey D. | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 4,210 | — | $0 | 0 | SEC↗ |
| Stewart Stacey D. | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 4,536 | — | $0 | 0 | SEC↗ |
| Stewart Stacey D. | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 5,535 | — | $0 | 0 | SEC↗ |
| Stewart Stacey D. | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 768 | — | $0 | 0 | SEC↗ |
| Wendell Amy McBride | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 5,535 | — | $0 | 0 | SEC↗ |
| Wendell Amy McBride | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 4,536 | — | $0 | 0 | SEC↗ |
| Wendell Amy McBride | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 4,210 | — | $0 | 0 | SEC↗ |
| Wendell Amy McBride | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 5,293 | — | $0 | 0 | SEC↗ |
| Wendell Amy McBride | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 5,055 | — | $0 | 0 | SEC↗ |
| Wendell Amy McBride | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 7,322 | — | $0 | 0 | SEC↗ |
| Wendell Amy McBride | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 6,523 | — | $0 | 0 | SEC↗ |
| Wendell Amy McBride | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 7,551 | — | $0 | 0 | SEC↗ |
| Wendell Amy McBride | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 6,816 | — | $0 | 0 | SEC↗ |
| Wendell Amy McBride | Director | D To issuer deriv | 2026-04-07 | 2026-04-09 | 1,500 | — | $0 | 0 | SEC↗ |
| Horvath Mark W. | President, Breast & Skeletal | D To issuer deriv | 2026-04-07 | 2026-04-09 | 3,509 | — | $0 | 0 | SEC↗ |
| Horvath Mark W. | President, Breast & Skeletal | A Award deriv | 2026-04-07 | 2026-04-09 | 7,762 | — | $0 | 7,762 | SEC↗ |
| Horvath Mark W. | President, Breast & Skeletal | D To issuer deriv | 2026-04-07 | 2026-04-09 | 2,844 | — | $0 | 0 | SEC↗ |
| Horvath Mark W. | President, Breast & Skeletal | D To issuer deriv | 2026-04-07 | 2026-04-09 | 3,505 | — | $0 | 0 | SEC↗ |
| Horvath Mark W. | President, Breast & Skeletal | D To issuer deriv | 2026-04-07 | 2026-04-09 | 7,762 | — | $0 | 0 | SEC↗ |
| Horvath Mark W. | President, Breast & Skeletal | D To issuer deriv | 2026-04-07 | 2026-04-09 | 2,899 | — | $0 | 0 | SEC↗ |
| Horvath Mark W. | President, Breast & Skeletal | D To issuer deriv | 2026-04-07 | 2026-04-09 | 5,349 | — | $0 | 0 | SEC↗ |
| Horvath Mark W. | President, Breast & Skeletal | D To issuer deriv | 2026-04-07 | 2026-04-09 | 2,490 | — | $0 | 0 | SEC↗ |
| Liddy Anne M. | General Counsel | D To issuer deriv | 2026-04-07 | 2026-04-09 | 6,016 | — | $0 | 0 | SEC↗ |
| Liddy Anne M. | General Counsel | A Award deriv | 2026-04-07 | 2026-04-09 | 3,452 | — | $0 | 3,452 | SEC↗ |
| Liddy Anne M. | General Counsel | D To issuer deriv | 2026-04-07 | 2026-04-09 | 4,683 | — | $0 | 0 | SEC↗ |
| Liddy Anne M. | General Counsel | D To issuer deriv | 2026-04-07 | 2026-04-09 | 7,479 | — | $0 | 0 | SEC↗ |
| Liddy Anne M. | General Counsel | D To issuer deriv | 2026-04-07 | 2026-04-09 | 3,452 | — | $0 | 0 | SEC↗ |
| Liddy Anne M. | General Counsel | D To issuer deriv | 2026-04-07 | 2026-04-09 | 5,121 | — | $0 | 0 | SEC↗ |
| Liddy Anne M. | General Counsel | D To issuer deriv | 2026-04-07 | 2026-04-09 | 5,943 | — | $0 | 0 | SEC↗ |
| Liddy Anne M. | General Counsel | D To issuer deriv | 2026-04-07 | 2026-04-09 | 6,129 | — | $0 | 0 | SEC↗ |
| Liddy Anne M. | General Counsel | D To issuer deriv | 2026-04-07 | 2026-04-09 | 2,173 | — | $0 | 0 | SEC↗ |
| Mitchell Essex D | Chief Operating Officer | D To issuer deriv | 2026-04-07 | 2026-04-09 | 25,070 | — | $0 | 0 | SEC↗ |
| Mitchell Essex D | Chief Operating Officer | A Award deriv | 2026-04-07 | 2026-04-09 | 46,154 | — | $0 | 46,154 | SEC↗ |
| Mitchell Essex D | Chief Operating Officer | D To issuer deriv | 2026-04-07 | 2026-04-09 | 32,722 | — | $0 | 0 | SEC↗ |
| Mitchell Essex D | Chief Operating Officer | D To issuer deriv | 2026-04-07 | 2026-04-09 | 46,154 | — | $0 | 0 | SEC↗ |
| Mitchell Essex D | Chief Operating Officer | D To issuer deriv | 2026-04-07 | 2026-04-09 | 11,596 | — | $0 | 0 | SEC↗ |
| Mitchell Essex D | Chief Operating Officer | D To issuer deriv | 2026-04-07 | 2026-04-09 | 2,972 | — | $0 | 0 | SEC↗ |
| Oberton Karleen Marie | Chief Financial Officer | D To issuer deriv | 2026-04-07 | 2026-04-09 | 21,743 | — | $0 | 0 | SEC↗ |
| Oberton Karleen Marie | Chief Financial Officer | D To issuer deriv | 2026-04-07 | 2026-04-09 | 30,774 | — | $0 | 0 | SEC↗ |
| Oberton Karleen Marie | Chief Financial Officer | A Award deriv | 2026-04-07 | 2026-04-09 | 42,707 | — | $0 | 42,707 | SEC↗ |
| Oberton Karleen Marie | Chief Financial Officer | D To issuer deriv | 2026-04-07 | 2026-04-09 | 28,047 | — | $0 | 0 | SEC↗ |
| Oberton Karleen Marie | Chief Financial Officer | D To issuer deriv | 2026-04-07 | 2026-04-09 | 25,070 | — | $0 | 0 | SEC↗ |
| Oberton Karleen Marie | Chief Financial Officer | D To issuer deriv | 2026-04-07 | 2026-04-09 | 42,707 | — | $0 | 0 | SEC↗ |
| Oberton Karleen Marie | Chief Financial Officer | D To issuer deriv | 2026-04-07 | 2026-04-09 | 23,775 | — | $0 | 0 | SEC↗ |
| Oberton Karleen Marie | Chief Financial Officer | D To issuer deriv | 2026-04-07 | 2026-04-09 | 23,767 | — | $0 | 0 | SEC↗ |
| Schneiders Jennifer M | President, Diag. Solutions | D To issuer deriv | 2026-04-07 | 2026-04-09 | 4,058 | — | $0 | 0 | SEC↗ |
| Schneiders Jennifer M | President, Diag. Solutions | D To issuer deriv | 2026-04-07 | 2026-04-09 | 3,804 | — | $0 | 0 | SEC↗ |
| Schneiders Jennifer M | President, Diag. Solutions | D To issuer deriv | 2026-04-07 | 2026-04-09 | 22,598 | — | $0 | 0 | SEC↗ |
| Schneiders Jennifer M | President, Diag. Solutions | A Award deriv | 2026-04-07 | 2026-04-09 | 22,598 | — | $0 | 22,598 | SEC↗ |
| Schneiders Jennifer M | President, Diag. Solutions | D To issuer deriv | 2026-04-07 | 2026-04-09 | 18,698 | — | $0 | 0 | SEC↗ |
| Schneiders Jennifer M | President, Diag. Solutions | D To issuer deriv | 2026-04-07 | 2026-04-09 | 10,028 | — | $0 | 0 | SEC↗ |
| Schnittker Brandon | President, GYN Surgical | D To issuer deriv | 2026-04-07 | 2026-04-09 | 8,432 | — | $0 | 0 | SEC↗ |
| Schnittker Brandon | President, GYN Surgical | A Award deriv | 2026-04-07 | 2026-04-09 | 8,432 | — | $0 | 8,432 | SEC↗ |
| Schnittker Brandon | President, GYN Surgical | D To issuer deriv | 2026-04-07 | 2026-04-09 | 8,414 | — | $0 | 0 | SEC↗ |
| Schnittker Brandon | President, GYN Surgical | D To issuer deriv | 2026-04-07 | 2026-04-09 | 2,538 | — | $0 | 0 | SEC↗ |
| Schnittker Brandon | President, GYN Surgical | D To issuer deriv | 2026-04-07 | 2026-04-09 | 5,014 | — | $0 | 0 | SEC↗ |
| Schnittker Brandon | President, GYN Surgical | D To issuer deriv | 2026-04-07 | 2026-04-09 | 3,865 | — | $0 | 0 | SEC↗ |
| Schnittker Brandon | President, GYN Surgical | D To issuer deriv | 2026-04-07 | 2026-04-09 | 2,265 | — | $0 | 0 | SEC↗ |
| Verstreken Jan | Group President, Internation | D To issuer deriv | 2026-04-07 | 2026-04-09 | 20,056 | — | $0 | 0 | SEC↗ |
| Verstreken Jan | Group President, Internation | D To issuer deriv | 2026-04-07 | 2026-04-09 | 19,327 | — | $0 | 0 | SEC↗ |
| Verstreken Jan | Group President, Internation | D To issuer deriv | 2026-04-07 | 2026-04-09 | 18,698 | — | $0 | 0 | SEC↗ |
| Verstreken Jan | Group President, Internation | A Award deriv | 2026-04-07 | 2026-04-09 | 31,409 | — | $0 | 31,409 | SEC↗ |
| Verstreken Jan | Group President, Internation | D To issuer deriv | 2026-04-07 | 2026-04-09 | 31,409 | — | $0 | 0 | SEC↗ |
| Verstreken Jan | Group President, Internation | D To issuer deriv | 2026-04-07 | 2026-04-09 | 7,564 | — | $0 | 0 | SEC↗ |
| Verstreken Jan | Group President, Internation | D To issuer deriv | 2026-04-07 | 2026-04-09 | 12,490 | — | $0 | 0 | SEC↗ |
| Verstreken Jan | Group President, Internation | D To issuer deriv | 2026-04-07 | 2026-04-09 | 13,971 | — | $0 | 0 | SEC↗ |
| Verstreken Jan | Group President, Internation | D To issuer deriv | 2026-04-07 | 2026-04-09 | 17,831 | — | $0 | 0 | SEC↗ |
| Verstreken Jan | Group President, Internation | D To issuer deriv | 2026-04-07 | 2026-04-09 | 12,509 | — | $0 | 0 | SEC↗ |
| Verstreken Jan | Group President, Internation | D To issuer deriv | 2026-04-07 | 2026-04-09 | 29,002 | — | $0 | 0 | SEC↗ |
| Verstreken Jan | Group President, Internation | D To issuer deriv | 2026-04-07 | 2026-04-09 | 15,387 | — | $0 | 0 | SEC↗ |
| COHN BENJAMIN JORDAN | Principal Accounting Officer | D To issuer | 2026-04-07 | 2026-04-09 | 17,964 | — | $0 | 0 | SEC↗ |
| Dockendorff Charles J | Director | D To issuer | 2026-04-07 | 2026-04-09 | 15,370 | — | $0 | 0 | SEC↗ |
| Dockendorff Charles J | Director | D To issuer | 2026-04-07 | 2026-04-09 | 6,626 | — | $0 | 0 | SEC↗ |
| HANTSON LUDWIG | Director | D To issuer | 2026-04-07 | 2026-04-09 | 16,146 | — | $0 | 0 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | D To issuer | 2026-04-07 | 2026-04-09 | 1,423,837 | — | $0 | 0 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | D To issuer | 2026-04-07 | 2026-04-09 | 1,146,829 | — | $0 | 0 | SEC↗ |
| Madaus Martin D | Director | D To issuer | 2026-04-07 | 2026-04-09 | 5,396 | — | $0 | 0 | SEC↗ |
| Madaus Martin D | Director | D To issuer | 2026-04-07 | 2026-04-09 | 5,445 | — | $0 | 0 | SEC↗ |
| McMillan Wayde D. | Director | D To issuer | 2026-04-07 | 2026-04-09 | 4,932 | — | $0 | 0 | SEC↗ |
| Mohtashami Nanaz | Director | D To issuer | 2026-04-07 | 2026-04-09 | 7,371 | — | $0 | 0 | SEC↗ |
| Stamoulis Christiana | Director | D To issuer | 2026-04-07 | 2026-04-09 | 50,526 | — | $0 | 0 | SEC↗ |
| Stewart Stacey D. | Director | D To issuer | 2026-04-07 | 2026-04-09 | 8,358 | — | $0 | 0 | SEC↗ |
| Wendell Amy McBride | Director | D To issuer | 2026-04-07 | 2026-04-09 | 25,784 | — | $0 | 0 | SEC↗ |
| De Walt Diana | SVP, Human Resources | D To issuer | 2026-04-07 | 2026-04-09 | 7,603 | — | $0 | 0 | SEC↗ |
| Horvath Mark W. | President, Breast & Skeletal | D To issuer | 2026-04-07 | 2026-04-09 | 23,026 | — | $0 | 0 | SEC↗ |
| Liddy Anne M. | General Counsel | D To issuer | 2026-04-07 | 2026-04-09 | 28,052 | — | $0 | 0 | SEC↗ |
| Mitchell Essex D | Chief Operating Officer | D To issuer | 2026-04-07 | 2026-04-09 | 77,694 | — | $0 | 0 | SEC↗ |
| Oberton Karleen Marie | Chief Financial Officer | D To issuer | 2026-04-07 | 2026-04-09 | 150,735 | — | $0 | 0 | SEC↗ |
| Schneiders Jennifer M | President, Diag. Solutions | D To issuer | 2026-04-07 | 2026-04-09 | 41,462 | — | $0 | 0 | SEC↗ |
| Schnittker Brandon | President, GYN Surgical | D To issuer | 2026-04-07 | 2026-04-09 | 17,644 | — | $0 | 0 | SEC↗ |
| Verstreken Jan | Group President, Internation | D To issuer | 2026-04-07 | 2026-04-09 | 134,039 | — | $0 | 0 | SEC↗ |
| Liddy Anne M. | General Counsel | F Tax w/h | 2026-02-27 | 2026-03-02 | 185 | $75.36 | $13.9K | 28,052 | SEC↗ |
| Dockendorff Charles J | Director | A Award | 2026-02-26 | 2026-03-02 | 3,190 | — | $0 | 6,626 | SEC↗ |
| HANTSON LUDWIG | Director | A Award | 2026-02-26 | 2026-03-02 | 3,190 | — | $0 | 16,146 | SEC↗ |
| Madaus Martin D | Director | A Award | 2026-02-26 | 2026-03-02 | 3,190 | — | $0 | 5,396 | SEC↗ |
| McMillan Wayde D. | Director | A Award | 2026-02-26 | 2026-03-02 | 3,190 | — | $0 | 4,932 | SEC↗ |
| Mohtashami Nanaz | Director | A Award | 2026-02-26 | 2026-03-02 | 3,190 | — | $0 | 7,371 | SEC↗ |
| Stamoulis Christiana | Director | A Award | 2026-02-26 | 2026-03-02 | 3,190 | — | $0 | 50,526 | SEC↗ |
| Stewart Stacey D. | Director | A Award | 2026-02-26 | 2026-03-02 | 3,190 | — | $0 | 8,358 | SEC↗ |
| Wendell Amy McBride | Director | A Award | 2026-02-26 | 2026-03-02 | 3,190 | — | $0 | 25,784 | SEC↗ |
| Horvath Mark W. | President, Breast & Skeletal | F Tax w/h | 2026-02-10 | 2026-02-12 | 113 | $75.15 | $8.5K | 23,026 | SEC↗ |
| De Walt Diana | SVP, Human Resources | F Tax w/h | 2026-01-30 | 2026-02-03 | 4,416 | $74.93 | $330.9K | 7,603 | SEC↗ |
| De Walt Diana | SVP, Human Resources | F Tax w/h | 2026-01-30 | 2026-02-03 | 4,416 | $74.93 | $330.9K | 7,603 | SEC↗ |
| Schnittker Brandon | President, GYN Surgical | F Tax w/h | 2025-12-12 | 2025-12-16 | 90 | $75.00 | $6.8K | 17,512 | SEC↗ |
| COHN BENJAMIN JORDAN | Principal Accounting Officer | F Tax w/h | 2025-11-14 | 2025-11-18 | 187 | $74.15 | $13.9K | 17,884 | SEC↗ |
| Liddy Anne M. | General Counsel | F Tax w/h | 2025-11-14 | 2025-11-18 | 337 | $74.15 | $25.0K | 28,237 | SEC↗ |
| Mitchell Essex D | Chief Operating Officer | F Tax w/h | 2025-11-14 | 2025-11-18 | 1,342 | $74.15 | $99.5K | 77,610 | SEC↗ |
| Oberton Karleen Marie | Chief Financial Officer | F Tax w/h | 2025-11-14 | 2025-11-18 | 1,333 | $74.15 | $98.8K | 150,735 | SEC↗ |
| Schneiders Jennifer M | President, Diag. Solutions | F Tax w/h | 2025-11-14 | 2025-11-18 | 561 | $74.15 | $41.6K | 41,318 | SEC↗ |
| Schnittker Brandon | President, GYN Surgical | F Tax w/h | 2025-11-14 | 2025-11-18 | 178 | $74.15 | $13.2K | 17,602 | SEC↗ |
| Verstreken Jan | Group President, Internation | F Tax w/h | 2025-11-14 | 2025-11-18 | 196 | $74.15 | $14.5K | 134,039 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | F Tax w/h | 2025-11-14 | 2025-11-18 | 6,874 | $74.15 | $509.7K | 1,423,837 | SEC↗ |
| Liddy Anne M. | General Counsel | F Tax w/h | 2025-11-11 | 2025-11-12 | 406 | $74.60 | $30.3K | 28,574 | SEC↗ |
| Mitchell Essex D | Chief Operating Officer | F Tax w/h | 2025-11-11 | 2025-11-12 | 1,701 | $74.60 | $126.9K | 78,952 | SEC↗ |
| Oberton Karleen Marie | Chief Financial Officer | F Tax w/h | 2025-11-11 | 2025-11-12 | 1,449 | $74.60 | $108.1K | 152,068 | SEC↗ |
| Schneiders Jennifer M | President, Diag. Solutions | F Tax w/h | 2025-11-11 | 2025-11-12 | 702 | $74.60 | $52.4K | 41,879 | SEC↗ |
| Schnittker Brandon | President, GYN Surgical | F Tax w/h | 2025-11-11 | 2025-11-12 | 289 | $74.60 | $21.6K | 17,780 | SEC↗ |
| Verstreken Jan | Group President, Internation | F Tax w/h | 2025-11-11 | 2025-11-12 | 178 | $74.60 | $13.3K | 134,235 | SEC↗ |
| COHN BENJAMIN JORDAN | Principal Accounting Officer | F Tax w/h | 2025-11-11 | 2025-11-12 | 181 | $74.60 | $13.5K | 18,071 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | F Tax w/h | 2025-11-11 | 2025-11-12 | 6,679 | $74.60 | $498.3K | 1,430,711 | SEC↗ |
| Liddy Anne M. | General Counsel | A Award | 2025-11-10 | 2025-11-12 | 17,496 | — | $0 | 28,980 | SEC↗ |
| Horvath Mark W. | President, Breast & Skeletal | A Award | 2025-11-10 | 2025-11-12 | 13,458 | — | $0 | 23,139 | SEC↗ |
| Mitchell Essex D | Chief Operating Officer | A Award | 2025-11-10 | 2025-11-12 | 47,106 | — | $0 | 80,653 | SEC↗ |
| Oberton Karleen Marie | Chief Financial Officer | A Award | 2025-11-10 | 2025-11-12 | 43,741 | — | $0 | 153,517 | SEC↗ |
| Schneiders Jennifer M | President, Diag. Solutions | A Award | 2025-11-10 | 2025-11-12 | 30,282 | — | $0 | 42,581 | SEC↗ |
| Schnittker Brandon | President, GYN Surgical | A Award | 2025-11-10 | 2025-11-12 | 12,113 | — | $0 | 18,069 | SEC↗ |
| Verstreken Jan | Group President, Internation | A Award | 2025-11-10 | 2025-11-12 | 16,823 | — | $0 | 134,413 | SEC↗ |
| COHN BENJAMIN JORDAN | Principal Accounting Officer | A Award | 2025-11-10 | 2025-11-12 | 5,047 | — | $0 | 18,252 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | A Award | 2025-11-10 | 2025-11-12 | 169,582 | — | $0 | 1,437,390 | SEC↗ |
| Liddy Anne M. | General Counsel | F Tax w/h | 2025-11-07 | 2025-11-12 | 288 | $74.10 | $21.3K | 11,484 | SEC↗ |
| Mitchell Essex D | Chief Operating Officer | F Tax w/h | 2025-11-07 | 2025-11-12 | 3,927 | $74.10 | $291.0K | 33,547 | SEC↗ |
| Oberton Karleen Marie | Chief Financial Officer | F Tax w/h | 2025-11-07 | 2025-11-12 | 9,427 | $74.10 | $698.5K | 109,776 | SEC↗ |
| Schneiders Jennifer M | President, Diag. Solutions | F Tax w/h | 2025-11-07 | 2025-11-12 | 158 | $74.10 | $11.7K | 12,299 | SEC↗ |
| Schnittker Brandon | President, GYN Surgical | F Tax w/h | 2025-11-07 | 2025-11-12 | 138 | $74.10 | $10.2K | 5,956 | SEC↗ |
| Verstreken Jan | Group President, Internation | F Tax w/h | 2025-11-07 | 2025-11-12 | 1,420 | $74.10 | $105.2K | 117,590 | SEC↗ |
| COHN BENJAMIN JORDAN | Principal Accounting Officer | F Tax w/h | 2025-11-07 | 2025-11-12 | 1,078 | $74.10 | $79.9K | 13,205 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | F Tax w/h | 2025-11-07 | 2025-11-12 | 50,405 | $74.10 | $3.74M | 1,267,808 | SEC↗ |
| COHN BENJAMIN JORDAN | Principal Accounting Officer | A Award | 2025-11-04 | 2025-11-06 | 2,656 | — | $0 | 14,283 | SEC↗ |
| Horvath Mark W. | President, Breast & Skeletal | A Award | 2025-11-04 | 2025-11-06 | 2,278 | — | $0 | 9,681 | SEC↗ |
| Mitchell Essex D | Chief Operating Officer | A Award | 2025-11-04 | 2025-11-06 | 9,116 | — | $0 | 37,474 | SEC↗ |
| Oberton Karleen Marie | Chief Financial Officer | A Award | 2025-11-04 | 2025-11-06 | 17,095 | — | $0 | 119,203 | SEC↗ |
| Verstreken Jan | Group President, Internation | A Award | 2025-11-04 | 2025-11-06 | 15,196 | — | $0 | 119,010 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | A Award | 2025-11-04 | 2025-11-06 | 83,589 | — | $0 | 1,318,213 | SEC↗ |
| Stamoulis Christiana | Director | M Exercise deriv | 2025-10-20 | 2025-10-22 | 7,402 | — | $0 | 0 | SEC↗ |
| Stamoulis Christiana | Director | S Sale | 2025-10-20 | 2025-10-22 | 7,402 | $73.07 | $540.9K | 47,336 | SEC↗ |
| Stamoulis Christiana | Director | M Exercise | 2025-10-20 | 2025-10-22 | 7,402 | $36.04 | $266.8K | 54,738 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | M Exercise deriv | 2025-09-22 | 2025-09-23 | 138,358 | — | $0 | 0 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | S Sale | 2025-09-22 | 2025-09-23 | 77,418 | $67.04 | $5.19M | 1,273,324 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | S Sale | 2025-09-22 | 2025-09-23 | 38,700 | $67.32 | $2.61M | 1,234,624 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | S Sale | 2025-09-22 | 2025-09-23 | 22,240 | $66.13 | $1.47M | 1,350,742 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | M Exercise | 2025-09-22 | 2025-09-23 | 138,358 | $39.96 | $5.53M | 1,372,982 | SEC↗ |
| Schnittker Brandon | Div. President, GYN Surgical | F Tax w/h | 2025-05-30 | 2025-06-03 | 69 | $62.17 | $4.3K | 6,094 | SEC↗ |
| Madaus Martin D | Director | P Buy | 2025-05-07 | 2025-05-09 | 5,445 | $55.24 | $300.8K | 5,445 | SEC↗ |
| McMillan Wayde D. | Director | A Award deriv | 2025-04-07 | 2025-04-09 | 5,171 | — | $0 | 5,171 | SEC↗ |
| McMillan Wayde D. | Director | A Award | 2025-04-07 | 2025-04-09 | 1,742 | — | $0 | 1,742 | SEC↗ |
| Dockendorff Charles J | Director | A Award deriv | 2025-02-26 | 2025-02-28 | 5,535 | — | $0 | 5,535 | SEC↗ |
| HANTSON LUDWIG | Director | A Award deriv | 2025-02-26 | 2025-02-28 | 5,535 | — | $0 | 5,535 | SEC↗ |
| Madaus Martin D | Director | A Award deriv | 2025-02-26 | 2025-02-28 | 5,535 | — | $0 | 5,535 | SEC↗ |
| Mohtashami Nanaz | Director | A Award deriv | 2025-02-26 | 2025-02-28 | 5,535 | — | $0 | 5,535 | SEC↗ |
| Stamoulis Christiana | Director | A Award deriv | 2025-02-26 | 2025-02-28 | 5,535 | — | $0 | 5,535 | SEC↗ |
| Stewart Stacey D. | Director | A Award deriv | 2025-02-26 | 2025-02-28 | 5,535 | — | $0 | 5,535 | SEC↗ |
| Wendell Amy McBride | Director | A Award deriv | 2025-02-26 | 2025-02-28 | 5,535 | — | $0 | 5,535 | SEC↗ |
| Dockendorff Charles J | Director | A Award | 2025-02-26 | 2025-02-28 | 1,864 | — | $0 | 3,436 | SEC↗ |
| HANTSON LUDWIG | Director | A Award | 2025-02-26 | 2025-02-28 | 1,864 | — | $0 | 12,956 | SEC↗ |
| Madaus Martin D | Director | A Award | 2025-02-26 | 2025-02-28 | 1,864 | — | $0 | 2,206 | SEC↗ |
| Mohtashami Nanaz | Director | A Award | 2025-02-26 | 2025-02-28 | 1,864 | — | $0 | 4,181 | SEC↗ |
| Stamoulis Christiana | Director | A Award | 2025-02-26 | 2025-02-28 | 1,864 | — | $0 | 47,336 | SEC↗ |
| Stewart Stacey D. | Director | A Award | 2025-02-26 | 2025-02-28 | 1,864 | — | $0 | 5,168 | SEC↗ |
| Wendell Amy McBride | Director | A Award | 2025-02-26 | 2025-02-28 | 1,864 | — | $0 | 22,594 | SEC↗ |
| Horvath Mark W. | Div. Pres., Breast & Skeleta | A Award deriv | 2025-02-10 | 2025-02-12 | 2,844 | — | $0 | 2,844 | SEC↗ |
| Horvath Mark W. | Div. Pres., Breast & Skeleta | A Award | 2025-02-10 | 2025-02-12 | 958 | — | $0 | 7,057 | SEC↗ |
| Schnittker Brandon | Div. President, GYN Surgical | F Tax w/h | 2024-12-13 | 2024-12-17 | 90 | $73.65 | $6.6K | 6,163 | SEC↗ |
| Madaus Martin D | Director | A Award | 2024-12-09 | 2024-12-11 | 342 | — | $0 | 342 | SEC↗ |
| Mitchell Essex D | Chief Operating Officer | M Exercise deriv | 2024-12-04 | 2024-12-06 | 8,915 | — | $0 | 2,972 | SEC↗ |
| Mitchell Essex D | Chief Operating Officer | M Exercise deriv | 2024-12-04 | 2024-12-06 | 1,956 | — | $0 | 0 | SEC↗ |
| Mitchell Essex D | Chief Operating Officer | M Exercise deriv | 2024-12-04 | 2024-12-06 | 4,526 | — | $0 | 0 | SEC↗ |
| Mitchell Essex D | Chief Operating Officer | M Exercise deriv | 2024-12-04 | 2024-12-06 | 7,505 | — | $0 | 0 | SEC↗ |
| Mitchell Essex D | Chief Operating Officer | M Exercise | 2024-12-04 | 2024-12-06 | 4,526 | $45.61 | $206.4K | 36,393 | SEC↗ |
| Mitchell Essex D | Chief Operating Officer | M Exercise | 2024-12-04 | 2024-12-06 | 1,956 | $40.97 | $80.1K | 31,867 | SEC↗ |
| Mitchell Essex D | Chief Operating Officer | M Exercise | 2024-12-04 | 2024-12-06 | 7,505 | $68.35 | $513.0K | 43,898 | SEC↗ |
| Mitchell Essex D | Chief Operating Officer | M Exercise | 2024-12-04 | 2024-12-06 | 8,915 | $71.13 | $634.1K | 52,813 | SEC↗ |
| Mitchell Essex D | Chief Operating Officer | S Sale | 2024-12-04 | 2024-12-06 | 24,856 | $76.34 | $1.90M | 27,957 | SEC↗ |
| Anderson Erik S | Div. Pres., Breast & Skeleta | F Tax w/h | 2024-11-14 | 2024-11-18 | 390 | $77.54 | $30.2K | 23,231 | SEC↗ |
| COHN BENJAMIN JORDAN | Principal Accounting Officer | F Tax w/h | 2024-11-14 | 2024-11-18 | 110 | $77.54 | $8.5K | 11,250 | SEC↗ |
| Griffin John M. | General Counsel | F Tax w/h | 2024-11-14 | 2024-11-18 | 1,120 | $77.54 | $86.8K | 182,514 | SEC↗ |
| Mitchell Essex D | Chief Operating Officer | F Tax w/h | 2024-11-14 | 2024-11-18 | 1,341 | $77.54 | $104.0K | 29,911 | SEC↗ |
| Oberton Karleen Marie | Chief Financial Officer | F Tax w/h | 2024-11-14 | 2024-11-18 | 1,332 | $77.54 | $103.3K | 102,108 | SEC↗ |
| Schneiders Jennifer M | President, Diag. Solutions | F Tax w/h | 2024-11-14 | 2024-11-18 | 507 | $77.54 | $39.3K | 12,096 | SEC↗ |
| Schnittker Brandon | Div. President, GYN Surgical | F Tax w/h | 2024-11-14 | 2024-11-18 | 178 | $77.54 | $13.8K | 6,253 | SEC↗ |
| Verstreken Jan | Group President, Internation | F Tax w/h | 2024-11-14 | 2024-11-18 | 630 | $77.54 | $48.9K | 103,814 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | F Tax w/h | 2024-11-14 | 2024-11-18 | 6,860 | $77.54 | $531.9K | 1,234,278 | SEC↗ |
| Anderson Erik S | Div. Pres., Breast & Skeleta | A Award deriv | 2024-11-11 | 2024-11-12 | 14,023 | — | $0 | 14,023 | SEC↗ |
| COHN BENJAMIN JORDAN | Principal Accounting Officer | A Award deriv | 2024-11-11 | 2024-11-12 | 3,505 | — | $0 | 3,505 | SEC↗ |
| Griffin John M. | General Counsel | A Award deriv | 2024-11-11 | 2024-11-12 | 18,698 | — | $0 | 18,698 | SEC↗ |
| Mitchell Essex D | Chief Operating Officer | A Award deriv | 2024-11-11 | 2024-11-12 | 32,722 | — | $0 | 32,722 | SEC↗ |
| Oberton Karleen Marie | Chief Financial Officer | A Award deriv | 2024-11-11 | 2024-11-12 | 28,047 | — | $0 | 28,047 | SEC↗ |
| Schneiders Jennifer M | President, Diag. Solutions | A Award deriv | 2024-11-11 | 2024-11-12 | 18,698 | — | $0 | 18,698 | SEC↗ |
| Schnittker Brandon | Div. President, GYN Surgical | A Award deriv | 2024-11-11 | 2024-11-12 | 8,414 | — | $0 | 8,414 | SEC↗ |
| Verstreken Jan | Group President, Internation | A Award deriv | 2024-11-11 | 2024-11-12 | 18,698 | — | $0 | 18,698 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | A Award deriv | 2024-11-11 | 2024-11-12 | 117,801 | — | $0 | 117,801 | SEC↗ |
| Anderson Erik S | Div. Pres., Breast & Skeleta | A Award | 2024-11-11 | 2024-11-12 | 4,723 | — | $0 | 23,621 | SEC↗ |
| COHN BENJAMIN JORDAN | Principal Accounting Officer | A Award | 2024-11-11 | 2024-11-12 | 1,180 | — | $0 | 11,360 | SEC↗ |
| Griffin John M. | General Counsel | A Award | 2024-11-11 | 2024-11-12 | 6,298 | — | $0 | 183,634 | SEC↗ |
| Mitchell Essex D | Chief Operating Officer | A Award | 2024-11-11 | 2024-11-12 | 11,021 | — | $0 | 31,252 | SEC↗ |
| Oberton Karleen Marie | Chief Financial Officer | A Award | 2024-11-11 | 2024-11-12 | 9,447 | — | $0 | 103,440 | SEC↗ |
| Schneiders Jennifer M | President, Diag. Solutions | A Award | 2024-11-11 | 2024-11-12 | 6,298 | — | $0 | 12,603 | SEC↗ |
| Schnittker Brandon | Div. President, GYN Surgical | A Award | 2024-11-11 | 2024-11-12 | 2,834 | — | $0 | 6,431 | SEC↗ |
| Verstreken Jan | Group President, Internation | A Award | 2024-11-11 | 2024-11-12 | 6,298 | — | $0 | 104,444 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | A Award | 2024-11-11 | 2024-11-12 | 39,677 | — | $0 | 1,241,138 | SEC↗ |
| Anderson Erik S | Div. Pres., Breast & Skeleta | F Tax w/h | 2024-11-08 | 2024-11-12 | 1,397 | $78.76 | $110.0K | 18,898 | SEC↗ |
| COHN BENJAMIN JORDAN | Principal Accounting Officer | F Tax w/h | 2024-11-08 | 2024-11-12 | 190 | $78.76 | $15.0K | 10,180 | SEC↗ |
| Griffin John M. | General Counsel | F Tax w/h | 2024-11-08 | 2024-11-12 | 9,299 | $78.76 | $732.4K | 177,336 | SEC↗ |
| Mitchell Essex D | Chief Operating Officer | F Tax w/h | 2024-11-08 | 2024-11-12 | 4,383 | $78.76 | $345.2K | 20,231 | SEC↗ |
| Oberton Karleen Marie | Chief Financial Officer | F Tax w/h | 2024-11-08 | 2024-11-12 | 12,598 | $78.76 | $992.2K | 93,993 | SEC↗ |
| Schneiders Jennifer M | President, Diag. Solutions | F Tax w/h | 2024-11-08 | 2024-11-12 | 125 | $78.76 | $9.8K | 6,305 | SEC↗ |
| Verstreken Jan | Group President, Internation | F Tax w/h | 2024-11-08 | 2024-11-12 | 4,928 | $78.76 | $388.1K | 98,146 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | F Tax w/h | 2024-11-08 | 2024-11-12 | 68,447 | $78.76 | $5.39M | 1,201,461 | SEC↗ |
| Anderson Erik S | Div. Pres., Breast & Skeleta | F Tax w/h | 2024-11-07 | 2024-11-12 | 344 | $79.29 | $27.3K | 20,295 | SEC↗ |
| COHN BENJAMIN JORDAN | Principal Accounting Officer | F Tax w/h | 2024-11-07 | 2024-11-12 | 106 | $79.29 | $8.4K | 10,370 | SEC↗ |
| Griffin John M. | General Counsel | F Tax w/h | 2024-11-07 | 2024-11-12 | 592 | $79.29 | $46.9K | 186,635 | SEC↗ |
| Mitchell Essex D | Chief Operating Officer | F Tax w/h | 2024-11-07 | 2024-11-12 | 422 | $79.29 | $33.5K | 24,614 | SEC↗ |
| Oberton Karleen Marie | Chief Financial Officer | F Tax w/h | 2024-11-07 | 2024-11-12 | 1,161 | $79.29 | $92.1K | 106,591 | SEC↗ |
| Schneiders Jennifer M | President, Diag. Solutions | F Tax w/h | 2024-11-07 | 2024-11-12 | 157 | $79.29 | $12.4K | 6,430 | SEC↗ |
| Schnittker Brandon | Div. President, GYN Surgical | F Tax w/h | 2024-11-07 | 2024-11-12 | 138 | $79.29 | $10.9K | 3,597 | SEC↗ |
| Verstreken Jan | Group President, Internation | F Tax w/h | 2024-11-07 | 2024-11-12 | 601 | $79.29 | $47.7K | 103,074 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | F Tax w/h | 2024-11-07 | 2024-11-12 | 6,214 | $79.29 | $492.7K | 1,269,908 | SEC↗ |
| Anderson Erik S | Div. Pres., Breast & Skeleta | A Award | 2024-11-05 | 2024-11-07 | 4,149 | — | $0 | 20,639 | SEC↗ |
| Griffin John M. | General Counsel | A Award | 2024-11-05 | 2024-11-07 | 20,746 | — | $0 | 187,227 | SEC↗ |
| Mitchell Essex D | Chief Operating Officer | A Award | 2024-11-05 | 2024-11-07 | 11,854 | — | $0 | 25,036 | SEC↗ |
| Oberton Karleen Marie | Chief Financial Officer | A Award | 2024-11-05 | 2024-11-07 | 23,710 | — | $0 | 107,752 | SEC↗ |
| Verstreken Jan | Group President, Internation | A Award | 2024-11-05 | 2024-11-07 | 17,780 | — | $0 | 103,675 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | A Award | 2024-11-05 | 2024-11-07 | 118,560 | — | $0 | 1,276,122 | SEC↗ |
| Oberton Karleen Marie | Chief Financial Officer | M Exercise deriv | 2024-08-29 | 2024-09-03 | 6,725 | — | $0 | 0 | SEC↗ |
| Oberton Karleen Marie | Chief Financial Officer | M Exercise deriv | 2024-08-29 | 2024-09-03 | 26,080 | — | $0 | 0 | SEC↗ |
| Oberton Karleen Marie | Chief Financial Officer | M Exercise | 2024-08-29 | 2024-09-03 | 6,725 | $40.85 | $274.7K | 136,721 | SEC↗ |
| Oberton Karleen Marie | Chief Financial Officer | S Sale | 2024-08-29 | 2024-09-03 | 52,679 | $80.56 | $4.24M | 84,042 | SEC↗ |
| Oberton Karleen Marie | Chief Financial Officer | M Exercise | 2024-08-29 | 2024-09-03 | 26,080 | $40.97 | $1.07M | 129,996 | SEC↗ |
| Schnittker Brandon | Div. President, GYN Surgical | S Sale | 2024-08-06 | 2024-08-08 | 476 | $83.11 | $39.6K | 3,735 | SEC↗ |
| COHN BENJAMIN JORDAN | Principal Accounting Officer | S Sale | 2024-08-01 | 2024-08-05 | 5,093 | $81.99 | $417.6K | 10,476 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | M Exercise deriv | 2024-07-30 | 2024-08-01 | 44,039 | — | $0 | 0 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | S Sale | 2024-07-30 | 2024-08-01 | 16,177 | $81.44 | $1.32M | 1,177,790 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | S Sale | 2024-07-30 | 2024-08-01 | 7,634 | $80.60 | $615.3K | 1,193,967 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | M Exercise | 2024-07-30 | 2024-08-01 | 44,039 | $26.21 | $1.15M | 1,201,601 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | S Sale | 2024-07-30 | 2024-08-01 | 20,228 | $82.32 | $1.67M | 1,157,562 | SEC↗ |
| Stamoulis Christiana | Director | M Exercise deriv | 2024-07-17 | 2024-07-19 | 9,039 | — | $0 | 0 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | M Exercise deriv | 2024-07-17 | 2024-07-19 | 3,672 | — | $0 | 44,039 | SEC↗ |
| Stamoulis Christiana | Director | M Exercise | 2024-07-17 | 2024-07-19 | 9,039 | $26.74 | $241.7K | 54,511 | SEC↗ |
| Stamoulis Christiana | Director | S Sale | 2024-07-17 | 2024-07-19 | 9,039 | $79.50 | $718.6K | 45,472 | SEC↗ |
| MACMILLAN STEPHEN P | Chairman, President and CEO | S Sale | 2024-07-17 | 2024-07-19 | 3,672 | $80.13 | $294.2K | 1,157,562 | SEC↗ |